{"entity":{"id":"jeito-capital","kind":"company","name":"Jeito Capital","aka":[],"tldr":"Jeito Capital is a Paris fund that writes large cheques for European biotech companies so they can take drugs through late-stage trials without selling early. Cancer medicines are a recurring theme.","summary":"Jeito Capital is a Paris-based growth-stage life-science investor founded in 2018 by Rafaele Tordjman, with a stated focus on patient benefit and on giving European biopharma companies the capital to run pivotal programmes and build commercial capabilities in Europe rather than out-licensing early. It participates in and leads large Series B and C rounds, several of them in oncology; the portfolio links in OnCo are derived from the startup records that name it.","asOf":"2026-09-10","links":[{"label":"Official website","url":"https://www.jeito.life"}],"tags":["vc"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Paris","country":"FR","companyType":"investor","website":"https://www.jeito.life","founded":2018,"investors":[],"funding":[]},"route":"/companies/jeito-capital/","neighbours":{"company":[{"id":"adcendo","kind":"company","name":"Adcendo","route":"/companies/adcendo/"},{"id":"alentis-therapeutics","kind":"company","name":"Alentis Therapeutics","route":"/companies/alentis-therapeutics/"},{"id":"callio-therapeutics","kind":"company","name":"Callio Therapeutics","route":"/companies/callio-therapeutics/"},{"id":"neogene-therapeutics","kind":"company","name":"Neogene Therapeutics","route":"/companies/neogene-therapeutics/"}]}}